Trial on blood vessel markers in pregnancy with high blood pressure
Part of Heart & circulation, Infections, Women’s health & pregnancy clinical trials.
This study looks at tiny particles released from blood vessels in pregnant women with high blood pressure. The goal is to find better ways to detect and manage conditions like preeclampsia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and 18 years or older.
- You are carrying one baby (not twins or more).
- You have normal blood pressure, or have been diagnosed with gestational hypertension or preeclampsia.
- You do not have high blood pressure that started before pregnancy.
- You do not have diabetes, kidney disease, autoimmune disease, heart disease, active infection, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well your blood vessels work during pregnancy to help predict high blood pressure disorders. If you join, you will have extra monitoring and blood tests.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study measures blood vessel–related markers in pregnant people who already have high blood pressure or early preeclampsia. The goal is to predict who is more likely to get worse, so care can be better targeted.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This trial is looking for women with preeclampsia to help find markers in the blood that show how blood vessels are affected. The goal is to better understand the condition and possibly improve future care.
This study looks at women who develop high blood pressure or preeclampsia during pregnancy (after 22 weeks). Researchers want to understand these conditions better and how they affect mothers and babies.
Hear when a new Hypertensive Disorder of Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.